NOV 15, 2018 11:01 AM PST

A Subclass of Anti-Aging Compounds Serves as Alzheimer's Drug Candidates

WRITTEN BY: Nouran Amin

In a publication in Trends in Pharmacological Sciences, a subclass of anti-aging compounds, called geroneuroprotectors (GNPs), have been identified in research to hold a potential role in slowing the aging process in mice. Since aging is the greatest risk factor for Alzheimer's disease (AD)—GNPs mays serve as a potential drug candidate.

Credit: rdmag.com

Alzheimer’s disease is a progressive neurodegenerative disease that first deteriorates memory and thinking skills and, eventually, the ability to perform simple tasks. Although losing memory is common as people grow old, it is not considered a normal part of aging.

Watch a video about how Alzheimer's changes the brain:

"The argument for geroprotectors is that if one can extend the lifespan of model organisms, such as mice, and translate this effect to humans, then you should be able to slow down the appearance of many diseases that are associated with aging, such as Alzheimer's, Parkinson's, cancer and overall frailty," states Dave Schubert, first author, Salk Institute professor and head of Salk's Cellular Neurobiology Laboratory.

In the study researchers first focused on two medicinal properties found in plants fisetin, derived from fruits and vegetables, and curcumin, from the curry spice turmeric. Researchers used these compounds, to synthesize three AD drug candidates based on their ability to protect neurons from age-related toxicities in the brain. The compounds that were then synthesized are CMS121, CAD31, and J147.

"Since we found that the natural products curcumin and fisetin are also GNPs and commercially available as supplements, they could provide some therapeutic benefits right now," says Maher.

Credit: Clarke.edu

The lab has successfully shown that these synthetic compounds were able to reduce the molecular markers of aging. The researchers were able to examine that the molecular pathways associated with the AD drug candidates are the same as well-studied synthetic compounds previously shown to extend the lifespan of many animals.

Researchers are hoping to get two GNPs, CMS121 and J147, into clinical trials once FDA has approved. The study is believed to validate the drug discovery model in the promotion of healthy aging

"If these drugs have benefits for other body systems, such as maintaining kidney function and overall muscle health, they could be used in additional ways to treat or prevent the diseases of aging," Schubert says.

Source: Trends in Pharmacological Sciences, Salk Research Institute

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Drug Delays Type 1 Diabetes in High Risk Individuals
An immunotherapeutic, involving anti-CD3 monoclonal antibody (teplizumab), was seen to slow down the progression to clinical type 1 diabetes in high risk i...
SEP 15, 2019
Technology
SEP 15, 2019
Nanoemulsion: The new way to deliver drugs
Nanoemulsions are tiny droplets of one liquid suspended within another liquid. These emulsions are similar to the droplets that form when you shaking an oi...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Common Anticonvulsant Drug May Counteract Inflammation
Sepsis is a serious medical condition that results from inflammation in the body and can cause fatal multi-organ dysfunction. The inflammation is usually t...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Drug Targets Early Instigators of Alzheimer Disease
The two solidifying instigators of Alzheimer -disease (AD)—amyloid beta and the tau protein—have long been the topic of study for AD researcher...
SEP 15, 2019
Immunology
SEP 15, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Do Nootropics Really Boost Brain Function?
  Nootropics are a broad range of both natural and artificial compounds though to improve cognitive function. Including everything from caffeine to Ad...
Loading Comments...